The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular profiling of neoadjuvant immunochemotherapy and identification of residual cancer cells in pCR NSCLC: A single-cell analysis of CTONG 1804 clinical trial.
 
SiYang Liu
No Relationships to Disclose
 
Song Dong
No Relationships to Disclose
 
Si-Yang Liu
No Relationships to Disclose
 
Xue-Ning Yang
No Relationships to Disclose
 
Ri-qiang Liao
No Relationships to Disclose
 
Ben-Yuan Jiang
No Relationships to Disclose
 
Xiao-song Ben
No Relationships to Disclose
 
Jun-Tao Lin
No Relationships to Disclose
 
Hong-Hong Yan
No Relationships to Disclose
 
Lixu Yan
No Relationships to Disclose
 
Qiang Nie
No Relationships to Disclose
 
HaiYan Tu
No Relationships to Disclose
 
Bin-Chao Wang
No Relationships to Disclose
 
Jinji Yang
No Relationships to Disclose
 
Qing Zhou
Honoraria - AstraZeneca; Boehringer Ingelheim; Lilly; MSD; Pfizer; Roche
 
Wei-Chi Luo
No Relationships to Disclose
 
Chen Huang
No Relationships to Disclose
 
Jiayan Wu
Employment - Kanghui Biotech Co. LTD
Leadership - Kanghui Biotech Co. LTD
Stock and Other Ownership Interests - Kanghui Biotech Co. LTD
 
Wenzhao Zhong
Honoraria - AstraZeneca; Roche
 
Yi-Long Wu
Honoraria - AstraZeneca; BeiGene Beijing; Boehringer Ingelheim; Bristol-Myers Squibb/China; Hengrui Pharmaceutical; MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Roche; Takeda
Research Funding - BMS (Inst); Boehringer Ingelheim (Inst); Pfizer (Inst); Roche (Inst)